Precision BioSciences: Q3 Earnings Snapshot
Precision BioSciences: Q2 Earnings Snapshot
Stocks that traded heavily or had substantial price changes on Monday: Incyte, Squarespace rise; Chimera Investment, Amazon fall
Precision BioSciences: Q1 Earnings Snapshot
Precision BioSciences: Q4 Earnings Snapshot
Precision BioSciences: Q3 Earnings Snapshot
Precision BioSciences: Q2 Earnings Snapshot
Precision BioSciences: Q1 Earnings Snapshot
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that, on April...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that it will...